Eam Global Investors LLC Verastem, Inc. Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $1.32 Million - $2.11 Million	-519,251 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $1.33 Million - $2.52 Million	519,251 New	519,251 $2.11 Million
Q3 2018 Nov 08, 2018	SELL	$6.86 - $9.97 $1.02 Million - $1.49 Million	-149,119 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$2.88 - $8.67 $429,462 - $1.29 Million	149,119 New	149,119 $1.03 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.